Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phosphoinositide 3′-kinase delta: turning off BCR signaling in Chronic Lymphocytic Leukemia

15 Oct 2011

Abstract excerpt

PI3K signaling is now targeted in first clinical trials in patients with B cell malignancies, including Chronic Lymphocytic Leukemia (CLL), which represent one of the first molecularly targeted therapies for B cell malignancies.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to Immunodeficiency and Autoimmune Disorders
Share to PI3K/AKT/mTOR signaling in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22006556
DOI: 10.18632/oncotarget.341

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phosphoinositide 3′-kinase delta: turning off BCR signaling in Chronic Lymphocytic LeukemiaPMID 22006556Read ↗

B cell signalling pathways—New targets for precision medicine in chronic lymphocytic leukaemiaSemantic proximity Read ↗

Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia.Semantic proximity Read ↗

Molecular bases of chronic lymphocytic leukemia in light of new treatments.Semantic proximity Read ↗

Distinct roles for phosphoinositide 3-kinases γ and δ in malignant B cell migration.Semantic proximity Read ↗

Targeting B-cell receptor and PI3K signaling in diffuse large B-cell lymphomaSemantic proximity Read ↗

Targetable leukemia dependency on noncanonical PI3Kγ signalingSemantic proximity Read ↗

Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia.Semantic proximity Read ↗

Signaling pathways activated by the B-cell receptor in chronic lymphocytic leukemiaSemantic proximity Read ↗

<i>ABL</i> Oncogenes and Phosphoinositide 3-Kinase: Mechanism of Activation and Downstream EffectorsSemantic proximity Read ↗

Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in Preclinical ModelsSemantic proximity Read ↗

Idelalisib — A PI3Kδ Inhibitor for B-Cell CancersSemantic proximity Read ↗

PI3Kδ inhibition causes feedback activation of PI3Kα in the ABC subtype of diffuse large B-cell lymphomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.